Prof. Santos' team hires a Commerical Champion to strenghten our Business Finland project

Dr. Antti Rahikkala was hired as Commercial Champion for Business Finland R2B project. Dr. Rahikkala has extensive expertise on drug delivery development, startup company management, CEO expertise from Capsamedix, as well as has a wide network in the field of drug research in Finland and abroad.

Prof. Santos' Lab received a 2-year Business Finland R3B funding June 2020-May 2022, and the aim of this funding is to explore the commercialization potential of research results. Our project aims to find a commercialization route for our microneedles appracoh for drug delivery applications to pets.

Dr. Rahikkala is expected to further strenghten our activities in the commercialization aspects of our technology and we are very excited to have you on our team working torwards this goal.